The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Bioterrorism-Related Inhalational Anthrax: The First 10 Cases Reported in the United States
Open accessAbstract
From October 4 to November 2, 2001, the first 10 confirmed cases of inhalational anthrax caused by intentional release of Bacillus anthracis were identified in the United States. Epidemiologic investigation indicated that the outbreak, in the District of Columbia, Florida, New Jersey, and New York, resulted from intentional delivery of B. anthracis spores through mailed letters or packages. We describe the clinical presentation and course of these cases of bioterrorism-related inhalational anthrax. The median age of patients was 56 years (range 43 to 73 years), 70% were male, and except for one, all were known or believed to have processed, handled, or received letters containing B. anthracis spores. The median incubation period from the time of exposure to onset of symptoms, when known (n=6), was 4 days (range 4 to 6 days). Symptoms at initial presentation included fever or chills (n=10), sweats (n=7), fatigue or malaise (n=10), minimal or nonproductive cough (n=9), dyspnea (n=8), and nausea or vomiting (n=9). The median white blood cell count was 9.8 X 10(3)/mm(3) (range 7.5 to 13.3), often with increased neutrophils and band forms. Nine patients had elevated serum transaminase levels, and six were hypoxic. All 10 patients had abnormal chest X-rays; abnormalities included infiltrates (n=7), pleural effusion (n=8), and mediastinal widening (seven patients). Computed tomography of the chest was performed on eight patients, and mediastinal lymphadenopathy was present in seven. With multidrug antibiotic regimens and supportive care, survival of patients (60%) was markedly higher (<15%) than previously reported.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sverdlovsk Anthrax Outbreak of 1979
Meselson, M., Guillemin, J., Hugh-Jones, M., Langmuir, A., Popova, I., Shelokov, A., & Yampolskaya, O. (1994) · Science · doi:10.1126/science.7973702 · Cited by 1,006
Dixon, T. C., Meselson, M., Guillemin, J., & Hanna, P. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909093411107 · Cited by 874
Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979.
Abramova, F. A., Grinberg, L. M., Yampolskaya, O. V., & Walker, D. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2291 · Cited by 410
Cited by
Furin at the cutting edge: From protein traffic to embryogenesis and disease
Thomas, G. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm934 · Cited by 1,216
Anthrax as a Biological Weapon, 2002: Updated Recommendations for Management
Inglesby, T. V., O'Toole, T., Henderson, D. A., Bartlett, J. G., Ascher, M. S., Eitzen, E., Friedlander, A. M., Gerberding, J., Hauer, J., Hughes, J., et al. (2002) · JAMA · doi:10.1001/jama.287.17.2236 · Cited by 1,027
Self-citationMandell, L. A., Bartlett, J. G., Dowell, S. F., File, T. M., Musher, D. M., & Whitney, C. (2003) · Clinical Infectious Diseases · doi:10.1086/380488 · Cited by 1,004
Transmissibility of 1918 pandemic influenza
Mills, C. E., Robins, J. M., & Lipsitch, M. (2004) · Nature · doi:10.1038/nature03063 · Cited by 796
Investigation of Bioterrorism-Related Anthrax, United States, 2001: Epidemiologic Findings
Jernigan, D. B., Raghunathan, P. L., Bell, B. P., Brechner, R., Bresnitz, E. A., Butler, J. C., Cetron, M., Cohen, M., Doyle, T., Fischer, M., et al. (2002) · Emerging Infectious Diseases · doi:10.3201/eid0810.020353 · Cited by 709
Self-citationby, P., Bower, W. A., Hendricks, K., Pillai, S., Guarnizo, J., & Meaney-Delman, D. (2015) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6404a1 · Cited by 585
The Vulnerability of Science and the Science of Vulnerability
Cutter, S. L. (2003) · Annals of the Association of American Geographers · doi:10.1111/1467-8306.93101 · Cited by 572
The Bacillus cereus Group: Bacillus Species with Pathogenic Potential
Ehling-Schulz, M., Lereclus, D., & Koehler, T. M. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0032-2018 · Cited by 556
Genomics of the group of organisms
RASKO, D., ALTHERR, M., HAN, C., & RAVEL, J. (2005) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2004.12.005 · Cited by 470
Implementing Syndromic Surveillance: A Practical Guide Informed by the Early Experience
Mandl, K. D. (2003) · Journal of the American Medical Informatics Association · doi:10.1197/jamia.m1356 · Cited by 410
Barth, H., Aktories, K., Popoff, M. R., & Stiles, B. G. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.3.373-402.2004 · Cited by 399
Characterisation and identification of bacteria using SERS
Jarvis, R. M., & Goodacre, R. (2008) · Chemical Society Reviews · doi:10.1039/b705973f · Cited by 371
Anthrax: A disease of biowarfare and public health importance
Goel, A. K. (2015) · World Journal of Clinical Cases · doi:10.12998/wjcc.v3.i1.20 · Cited by 322
Bacillus anthracis lethal toxin induces TNF-α–independent hypoxia-mediated toxicity in mice
Moayeri, M., Haines, D., Young, H. A., & Leppla, S. H. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17991 · Cited by 296
Raxibacumab for the Treatment of Inhalational Anthrax
Migone, T.-S., Subramanian, G. M., Zhong, J., Healey, L. M., Corey, A., Devalaraja, M., Lo, L., Ullrich, S., Zimmerman, J., Chen, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810603 · Cited by 294
Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity
Maynard, J. A., Maassen, C. B. M., Leppla, S. H., Brasky, K., Patterson, J. L., Iverson, B. L., & Georgiou, G. (2002) · Nature Biotechnology · doi:10.1038/nbt0602-597 · Cited by 287
The roles of anthrax toxin in pathogenesis
Moayeri, M. (2004) · Current Opinion in Microbiology · doi:10.1016/j.mib.2003.12.001 · Cited by 277
Systematic Review: A Century of Inhalational Anthrax Cases from 1900 to 2005
Holty, J.-E. C., Bravata, D. M., Liu, H., Olshen, R. A., McDonald, K. M., & Owens, D. K. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-4-200602210-00009 · Cited by 274
Moayeri, M., Leppla, S. H., Vrentas, C., Pomerantsev, A. P., & Liu, S. (2015) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091014-104523 · Cited by 262
Bacillus anthracis requires siderophore biosynthesis for growth in macrophages and mouse virulence
Cendrowski, S., MacArthur, W., & Hanna, P. (2004) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03861.x · Cited by 229
Public health communications and alert fatigue
Baseman, J. G., Revere, D., Painter, I., Toyoji, M., Thiede, H., & Duchin, J. (2013) · BMC Health Services Research · doi:10.1186/1472-6963-13-295 · Cited by 105
Transcriptional profiling of Bacillus anthracis Sterne (34F2) during iron starvation
Carlson, P. E., Carr, K. A., Janes, B. K., Anderson, E. C., & Hanna, P. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006988 · Cited by 50
“Bacillus anthracis, the causative agent of anthrax, is a highly virulent pathogen that has been used in recent history as a biological weapon [1].”
Background
Metadata
- Authors
- Jernigan, J. A., Stephens, D. S., Ashford, D. A., Omenaca, C., Topiel, M. S., Galbraith, M., Tapper, M., Fisk, T. L., Zaki, S., Popovic, T., Meyer, R. F., Quinn, C. P., Harper, S. A., Fridkin, S. K., Sejvar, J. J., Shepard, C. W., McConnell, M., Guarner, J., Shieh, W.-J., Malecki, J. M., Gerberding, J. L., Hughes, J. M., Perkins, B. A., & members of the Anthrax Bioterrorism Investigation Team
- Venue
- Emerging Infectious Diseases
- Published
- 2001-12
- Volume
- 7
- Issue
- 6
- Pages
- 933-944
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- OpenAlex
- W2135069977
- Cited by
- 999
- References
- 4
- FWCI
- 23.67
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.